[LABP] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 29.54%
YoY- 36.82%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 -18,000 -
PBT -3,922 -6,034 -5,232 -7,896 -11,284 -14,864 -20,097 -66.45%
Tax -557 -445 -1,352 67 18 -89 320 -
NP -3,922 -5,589 -3,880 -7,963 -11,302 -14,775 -20,097 -66.45%
Tax Rate - - - - - - - -
Total Cost 3,922 5,589 3,880 7,963 11,302 14,775 2,097 51.97%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 111.65 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.63 -0.86 -0.96 -1.98 -2.81 -3.67 -5.20 -75.60%
EPS Diluted -0.63 -0.86 -0.96 -1.98 -2.81 -3.67 -5.20 -75.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.